Literature DB >> 12099970

Hepatic glucose production: therapeutic target in type 2 diabetes?

P Staehr1, O Hother-Nielsen, H Beck-Nielsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12099970     DOI： 10.1046/j.1463-1326.2002.00177.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN： 1462-8902            Impact factor:   6.577


× No keyword cloud information.
  2 in total

1.  Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse.

Authors:  Kristin A Anderson; Fumin Lin; Thomas J Ribar; Robert D Stevens; Michael J Muehlbauer; Christopher B Newgard; Anthony R Means
Journal:  Mol Endocrinol       Date:  2012-01-12

2.  An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia.

Authors:  S M Poucher; S Freeman; S J G Loxham; G Convey; J B Bartlett; J De Schoolmeester; J Teague; M Walker; A V Turnbull; A D Charles; F Carey; S Berg
Journal:  Br J Pharmacol       Date:  2007-10-15       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.